Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02333942 · ClinicalTrials.gov registry record
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
A clinical trial, sponsored by Jan Medical.
- Completed
- Registry status
- 41
- Enrollment target
NCT02333942: Completed study, sponsored by Jan Medical.
NCT02333942 is a clinical trial that has completed, run by Jan Medical. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02333942 has completed, sponsored by Jan Medical.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
This study is being performed to generate data regarding brain vibration /oscillation differences between individuals with dementia and normal controls. The purpose of this study is to compare signal patterns generated from the impact on the scalp from these brain oscillation patterns from individuals with Alzheimer's disease, Frontotemporal Lobar Degeneration, Mild Cognitive Impairment and Age-Matched Normal Controls.
Primary Outcome
Efficacy at identifying Dementia through identified signatures as compared with the clinical assessment made by the PI and any objective measures the PI uses to arrive at assessment.
Interventions
- DEVICE Nautilus NeuroWaveTM System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-02 |
What the finished NCT02333942 record still lists
NCT02333942 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Nautilus NeuroWaveTM System is the first listed.
NCT02333942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02333942 about?
NCT02333942 is a clinical study titled "Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia". This study is being performed to generate data regarding brain vibration /oscillation differences between individuals with dementia and normal controls. The purpose of this study is to compare signal patterns generated from the impact on the scalp from these brain oscillation patterns from individua...
What is the current status of trial NCT02333942?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2014-05. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02333942?
The interventions under investigation include: Nautilus NeuroWaveTM System (DEVICE).
Who is sponsoring clinical trial NCT02333942?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia